Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,620.00 GBX | +0.89% |
|
+2.84% | +25.69% |
06-13 | European Equities Traded in the US as American Depositary Receipts Slide Friday | MT |
06-13 | BRITISH AMERICAN TOBACCO : Barclays reaffirms its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 25.78B | 25.68B | 27.66B | 27.28B | 25.87B | |||||
Total Revenues | 25.78B | 25.68B | 27.66B | 27.28B | 25.87B | |||||
Cost of Goods Sold, Total | 4.14B | 4.6B | 4.8B | 4.89B | 4.57B | |||||
Gross Profit | 21.64B | 21.09B | 22.85B | 22.39B | 21.3B | |||||
Selling General & Admin Expenses, Total | 2.65B | 3.81B | 3.83B | 3.86B | 3.95B | |||||
Depreciation & Amortization - (IS) | 1.09B | 938M | 962M | 849M | 2.23B | |||||
Other Operating Expenses | 6.83B | 5.34B | 6.41B | 5.05B | 5.32B | |||||
Other Operating Expenses, Total | 10.57B | 10.09B | 11.2B | 9.75B | 11.5B | |||||
Operating Income | 11.07B | 11B | 11.65B | 12.64B | 9.8B | |||||
Interest Expense, Total | -1.81B | -1.5B | -1.66B | -1.83B | -1.77B | |||||
Interest And Investment Income | 50M | 35M | 92M | 186M | 251M | |||||
Net Interest Expenses | -1.76B | -1.47B | -1.57B | -1.64B | -1.52B | |||||
Income (Loss) On Equity Invest. | 455M | 415M | 442M | 585M | 1.9B | |||||
Currency Exchange Gains (Loss) | -225M | 171M | -491M | 432M | -2M | |||||
Other Non Operating Income (Expenses) | 234M | -166M | 324M | -620M | -111M | |||||
EBT, Excl. Unusual Items | 9.77B | 9.95B | 10.36B | 11.39B | 10.06B | |||||
Restructuring Charges | -408M | -150M | -774M | 2M | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -209M | -57M | - | -4.61B | -39M | |||||
Gain (Loss) On Sale Of Investments | - | -24M | - | - | -6M | |||||
Gain (Loss) On Sale Of Assets | - | -358M | 6M | -546M | 62M | |||||
Asset Writedown | - | -92M | -123M | -23.11B | -828M | |||||
Legal Settlements | -508M | -81M | -144M | -156M | -6.3B | |||||
Other Unusual Items | 25M | -26M | - | -29M | 590M | |||||
EBT, Incl. Unusual Items | 8.67B | 9.16B | 9.32B | -17.06B | 3.54B | |||||
Income Tax Expense | 2.11B | 2.19B | 2.48B | -2.87B | 357M | |||||
Earnings From Continuing Operations | 6.56B | 6.97B | 6.85B | -14.19B | 3.18B | |||||
Net Income to Company | 6.56B | 6.97B | 6.85B | -14.19B | 3.18B | |||||
Minority Interest | -164M | -173M | -180M | -178M | -113M | |||||
Net Income - (IS) | 6.4B | 6.8B | 6.67B | -14.37B | 3.07B | |||||
Preferred Dividend and Other Adjustments | - | 12M | 49M | 45M | 42M | |||||
Net Income to Common Incl Extra Items | 6.4B | 6.79B | 6.62B | -14.41B | 3.03B | |||||
Net Income to Common Excl. Extra Items | 6.4B | 6.79B | 6.62B | -14.41B | 3.03B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.8 | 2.97 | 2.93 | -6.47 | 1.37 | |||||
Basic EPS - Continuing Operations | 2.8 | 2.97 | 2.93 | -6.47 | 1.37 | |||||
Basic Weighted Average Shares Outstanding | 2.29B | 2.29B | 2.26B | 2.23B | 2.21B | |||||
Net EPS - Diluted | 2.79 | 2.96 | 2.92 | -6.47 | 1.36 | |||||
Diluted EPS - Continuing Operations | 2.79 | 2.96 | 2.92 | -6.47 | 1.36 | |||||
Diluted Weighted Average Shares Outstanding | 2.3B | 2.3B | 2.27B | 2.23B | 2.22B | |||||
Normalized Basic EPS | 2.6 | 2.64 | 2.79 | 3.11 | 2.79 | |||||
Normalized Diluted EPS | 2.59 | 2.63 | 2.78 | 3.11 | 2.78 | |||||
Dividend Per Share | 2.1 | 2.16 | 2.18 | 2.36 | 2.4 | |||||
Payout Ratio | 74.14 | 72.2 | 73.73 | -35.6 | 171.74 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 12.16B | 11.94B | 12.18B | 13.28B | 11.82B | |||||
EBITA | 11.41B | 11B | 11.65B | 12.88B | 11.45B | |||||
EBIT | 11.07B | 11B | 11.65B | 12.64B | 9.8B | |||||
EBITDAR | - | 11.95B | 12.2B | 13.29B | 11.83B | |||||
Effective Tax Rate - (Ratio) | 24.31 | 23.89 | 26.58 | 16.83 | 10.09 | |||||
Current Domestic Taxes | 38M | -25M | -3M | 32M | 103M | |||||
Current Foreign Taxes | 2.39B | 2.4B | 2.72B | 2.78B | 2.68B | |||||
Total Current Taxes | 2.42B | 2.38B | 2.72B | 2.81B | 2.78B | |||||
Total Deferred Taxes | -317M | -187M | -240M | -5.68B | -2.42B | |||||
Normalized Net Income | 5.94B | 6.05B | 6.29B | 6.94B | 6.18B | |||||
Interest on Long-Term Debt | - | 24M | 25M | 30M | 38M | |||||
Non-Cash Pension Expense | - | -28M | -29M | -33M | -39M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | 1.24B | 1.16B | 1.15B | 1.11B | |||||
Selling and Marketing Expenses | - | 1.24B | 1.16B | 1.15B | 1.11B | |||||
Research And Development Expense From Footnotes | 307M | 304M | 323M | 408M | 380M | |||||
Net Rental Expense, Total | - | 9M | 12M | 14M | 9M | |||||
Imputed Operating Lease Interest Expense | - | 2.59M | 3.85M | 4.91M | 3.32M | |||||
Imputed Operating Lease Depreciation | - | 6.41M | 8.15M | 9.09M | 5.68M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | 78M | 85M | - | 74M | |||||
Total Stock-Based Compensation | - | 78M | 85M | - | 74M |
- Stock Market
- Equities
- BATS Stock
- Financials British American Tobacco p.l.c.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition